Literature DB >> 6046860

Myasthenia gravis: brief guide to diagnosis and management.

C Herrmann.   

Abstract

Physicians should consider the possibility of myasthenia gravis in patients complaining of fluctuating muscle weakness and easy fatigability. The disorder may occur in either sex at any age. Repeated measurements of multiple muscle groups and functions to include baseline strength and response to a control as well as anticholinesterase drugs are desirable in reaching a diagnosis. Appropriate doses of anticholinesterase medication reduce weakness and fatigability in most patients. Selected patients may benefit from thymectomy. Patients in crisis failing to respond to anticholinesterase drugs, having difficulty maintaining a patent airway or adequate respiratory exchange are best managed by prompt tracheostomy using a cuffed tube, with adequate tracheobronchial toilet and mechanical respiratory assistance.

Entities:  

Mesh:

Year:  1967        PMID: 6046860      PMCID: PMC1502664     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  17 in total

1.  Histological changes in the striped muscles in myasthenia gravis.

Authors:  D S RUSSELL
Journal:  J Pathol Bacteriol       Date:  1953-04

2.  Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications.

Authors:  A J Strauss; C W Smith; G W Cage; H W van der Geld; D E McFarlin; M Barlow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

Review 3.  Myasthenia gravis as an autoimmune disease: clinical aspects.

Authors:  J A Simpson
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

4.  Morphology of the myasthenic neuromuscular junction.

Authors:  A L Woolf
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

5.  Crisis, precrisis and drug resistance in myasthenia gravis.

Authors:  G H Glaser
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

6.  Muscle lesions in myasthenia gravis.

Authors:  G M Fenichel
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

7.  Acetylcholine utulization in myasthenia gravis.

Authors:  S Thesleff
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

8.  Myasthenia gravis: evaluation of treatment in 1,355 patients.

Authors:  V P Perlo; D C Poskanzer; R S Schwab; H R Viets; K E Osserman; G Genkins
Journal:  Neurology       Date:  1966-05       Impact factor: 9.910

9.  Myasthenia gravis occurring in families.

Authors:  C Herrmann
Journal:  Neurology       Date:  1966-01       Impact factor: 9.910

10.  Critical reappraisal of the use of edrophonium (tensilon) chloride tests in myasthenia gravis and significance of clinical classification.

Authors:  K E Osserman; G Genkins
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

View more
  3 in total

Review 1.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

2.  Myasthenia gravis and the myasthenic syndrome.

Authors:  C Herrmann
Journal:  Calif Med       Date:  1970-09

3.  Serum enzyme levels in patients with myasthenia gravis afte aerobic and ischaemic exercise.

Authors:  J Kolins; J Gilroy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-02       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.